We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Remitly
RELY
$5.22B
| $312 | ﹤0.01% |
+15
| New | +$344 |
2025 Q1
0 quarters
|
|
3302
Herbalife
HLF
$1.53B
| $311 | ﹤0.01% |
+36
| New | +$256 |
2025 Q1
0 quarters
|
|
3303
Carriage Services
CSV
$574M
| $310 | ﹤0.01% |
8
| – | – |
2023 Q4
5 quarters
|
|
3304
Liberty Latin America Class A
LILA
$1.62B
| $310 | ﹤0.01% |
72
| – | – |
2021 Q4
13 quarters
|
|
3305
BioNTech
BNTX
$22.7B
| $305 | ﹤0.01% |
3
-252
| -99% | -$28.2K |
2020 Q2
19 quarters
|
|
3306
Bombardier Recreational Products
DOO
$3.97B
| $304 | ﹤0.01% |
9
-466
| -98% | -$20.5K |
2023 Q1
8 quarters
|
|
3307
Expensify
EXFY
$230M
| $304 | ﹤0.01% |
100
| – | – |
2024 Q2
3 quarters
|
|
3308
Sutro Biopharma
STRO
$190M
| $303 | ﹤0.01% |
47
| – | – |
2021 Q1
16 quarters
|
|
3309
American Assets Trust
AAT
$1.32B
| $302 | ﹤0.01% |
15
-73
| -83% | -$1.65K |
2020 Q2
19 quarters
|
|
3310
Invivyd
IVVD
$197M
| $300 | ﹤0.01% |
496
| – | – |
2024 Q3
2 quarters
|
|
3311
Northwest Natural Holdings
NWN
$2.04B
| $299 | ﹤0.01% |
7
+1
| +17% | +$41 |
2021 Q2
15 quarters
|
|
|
WSR
3312
DELISTED
Whitestone REIT
WSR
| $291 | ﹤0.01% |
+20
| New | +$275 |
2025 Q1
0 quarters
|
|
3313
DELISTED
Semler Scientific
SMLR
| $290 | ﹤0.01% |
+8
| New | +$375 |
2025 Q1
0 quarters
|
|
|
SNRE
3314
DELISTED
Sunrise Communications AG American Depositary Shares representing Class A shares
SNRE
| $290 | ﹤0.01% |
6
-776
| -99% | -$36.4K |
2024 Q4
1 quarter
|
|
3315
Aviat Networks
AVNW
$250M
| $288 | ﹤0.01% |
15
| – | – |
2023 Q4
5 quarters
|
|
3316
LandBridge Corporation
LB
$2.41B
| $288 | ﹤0.01% |
+4
| New | +$283 |
2025 Q1
0 quarters
|
|
3317
Iovance Biotherapeutics
IOVA
$6.67B
| $286 | ﹤0.01% |
86
-251
| -74% | -$1.29K |
2020 Q2
19 quarters
|
|
3318
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$857M
| $285 | ﹤0.01% |
19
| – | – |
2022 Q1
12 quarters
|
|
3319
First Watch Restaurant Group
FWRG
$763M
| $283 | ﹤0.01% |
17
+12
| +240% | +$231 |
2024 Q3
2 quarters
|
|
3320
Dyne Therapeutics
DYN
$2.86B
| $282 | ﹤0.01% |
27
| – | – |
2024 Q2
3 quarters
|
|
3321
iShares MSCI Poland ETF
EPOL
$847M
| $280 | ﹤0.01% |
10
| – | – |
2023 Q2
7 quarters
|
|
3322
Dime Commercial Bancshares
DCOM
$1.71B
| $279 | ﹤0.01% |
10
| – | – |
2023 Q2
7 quarters
|
|
3323
Keel Infrastructure Corp
KEEL
$1.59B
| $276 | ﹤0.01% |
350
| – | – |
2023 Q4
5 quarters
|
|
3324
Rayonier Advanced Materials
RYAM
$481M
| $276 | ﹤0.01% |
48
-4
| -8% | -$28 |
2024 Q4
1 quarter
|
|
3325
Xometry
XMTR
$5.71B
| $274 | ﹤0.01% |
+11
| New | +$346 |
2025 Q1
0 quarters
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.